Find trending articles through Social News Discovery®! Providing a collaboration of news through social media technologies.
Follow your friends and create your own Online Social Newspaper! Invite your friends to follow you from Facebook. Filter the news articles you see by section, clipper, or mood. Rate each article and comment on all news clips!
Receive site and email notifications about comments and news clips that you are collaborating on!
Get the latest news on the Everyone page, the viral and trending news clips will always be at the top! See the trending news and articles!
"The FDA has approved Erelzi for all indications included in the reference product label, including rheumatoid arthritis, plaque psoriasis, psoriatic arthritis, ankylosing spondylitis and polyarticular juvenile idiopathic arthritis. Erelzi is a biosimilar to Enbrel (etanercept, Amgen). Erelzi (etanercept-szzs, Sandoz) is the second biosimilar from Sandoz approved in the United States through the", www.healio.com
"BioWorld Online is the news service of record for the biotechnology industry and is updated every business morning. BioWorld Online will keep you up to date on all of the industry's business, science and regulatory news -- mergers and collaborations, FDA hearings and results, breakthroughs in research and much more.", www.bioworld.com
"U.S. regulators have approved the first near-copy of Enbrel, drugmaker Amgen's pricey biologic medicine for treating rheumatoid arthritis and other immune system disorders. Novartis also couldn't say when the new medicine will be launched by its Sandoz unit, which makes generic drugs and 'biosimilars' — nearly identical versions of biologic drugs produced in living cells.", www.sfchronicle.com